BackAziyo Biologics Overview

Aziyo Biologics Current Cash

Track Aziyo Biologics's current cash ($20M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$19.90M
134.07% YoYΔ $11.40M vs prior year quarter

Peer trimmed avg / median

Loading

Aziyo Biologics Current Cash History

Loading

Aziyo Biologics vs. peers: Current Cash Comparison

Loading

Aziyo Biologics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aziyo Biologics (AZYO) FAQ

Aziyo Biologics (AZYO) currently reports a current cash of $20M as of June 2026. That compares with $8.5M in the prior-year period — up 134.1% year over year. Use the charts on this page to explore Aziyo Biologics's current cash history and peer comparisons.

Aziyo Biologics's current cash increased from $8.5M to $20M — a 134.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aziyo Biologics reported $20M in current cash as of June 2026. That compares with $8.5M in the prior-year period — up 134.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aziyo Biologics, and consider following AZYO for alerts when major investors trade the stock.

Aziyo Biologics is classified in the Healthcare sector. On current cash, it currently shows $20M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AZYO with unrelated industries.